Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis (INFU/PARA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01540838|
Recruitment Status : Completed
First Posted : February 29, 2012
Results First Posted : September 24, 2019
Last Update Posted : September 24, 2019
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Drug: Infusion with paracetamol
Drug: Bolus without paracetamol
1128 patients were assessed for eligibility at the Hospital´s Emergency Service from Jan 2012 to Jan 2017.
753 were excluded and 375 enrolled and randomized.